Bottom line
How much do SHSSX and GGHCX overlap?
57% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 49.8% of SHSSX's assets and 44.1% of GGHCX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings SHSSX and GGHCX have in common
| Holding | % of SHSSX | % of GGHCX | Overlap |
|---|---|---|---|
| Eli Lilly & Company LLY | 12.29% | 10.59% | 10.59% |
| Johnson & Johnson JNJ | 8.77% | 6.76% | 6.76% |
| Unitedhealth Group Inc UNH | 6.10% | 6.17% | 6.10% |
| Merck & Company Inc MRK | 4.94% | 4.59% | 4.59% |
| Gilead Sciences Inc GILD | 4.19% | 3.63% | 3.63% |
| Abbvie Inc ABBV | 3.94% | 4.03% | 3.94% |
| Thermo Fisher Scientific Inc TMO | 3.02% | 1.55% | 1.55% |
| Vertex Pharmaceuticals Inc VRTX | 2.74% | 2.01% | 2.01% |
| Edwards Lifesciences Corp EW | 2.51% | 1.56% | 1.56% |
| Argenx Se ARGX | 1.26% | 3.24% | 1.26% |
Source: SEC Form N-PORT (periods May 29, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in SHSSX
- Amgen Inc — 3.37%
- Pfizer Inc — 2.61%
- Danaher Corp — 2.00%
- Abbott Laboratories — 1.97%
- Intuitive Surgical Inc — 1.95%
- Teva Pharmaceutical Industries Ltd — 1.87%
- Boston Scientific Corp — 1.59%
- Elevance Health Inc — 1.56%
- Biogen Inc — 1.21%
- Astrazeneca Plc — 1.21%
- Stryker Corp — 1.15%
- Blackrock Funds III — 1.01%
- Revolution Medicines Inc — 0.96%
- Humana Inc — 0.92%
- Regeneron Pharmaceuticals Inc — 0.91%
Only in GGHCX
- Invesco Private Prime Fund — 4.67%
- CVS Health Corp. — 2.52%
- Welltower Inc. — 2.34%
- BrightSpring Health Services, Inc. — 2.20%
- Royalty Pharma PLC — 2.13%
- Cardinal Health, Inc. — 2.10%
- Guardant Health, Inc. — 2.04%
- Invesco Private Government Fund — 1.80%
- Axsome Therapeutics, Inc. — 1.58%
- Invesco Treasury Portfolio — 1.56%
- BridgeBio Pharma, Inc. — 1.43%
- Waters Corp. — 1.41%
- IQVIA Holdings Inc. — 1.32%
- U C B S.a. — 1.24%
- Ligand Pharmaceuticals Inc. — 1.18%
Asset mix
| Asset type | SHSSX | GGHCX |
|---|---|---|
| Stocks | 99.8% | 97.5% |
| Cash & short-term funds | 1.4% | 8.8% |
Source: SEC Form N-PORT (periods May 29, 2026 / Jul 31, 2026)
Country mix
| Country | SHSSX | GGHCX |
|---|---|---|
| US | 93.9% | 93.5% |
| NL | 1.3% | 3.4% |
| GB | 1.4% | 3.1% |
| CH | 1.4% | 2.7% |
| IL | 1.9% | 0.4% |
| BE | 0.3% | 1.2% |
| DK | — | 1.1% |
| IE | — | 0.6% |
Source: SEC Form N-PORT (periods May 29, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do SHSSX and GGHCX overlap?
What stocks do SHSSX and GGHCX have in common?
Should I own both SHSSX and GGHCX?
Which holds more stocks, SHSSX or GGHCX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.